ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,754, issued on Oct. 14, was assigned to GALECTO BIOTECH AB (Copenhagen, Denmark).
"Galactoside inhibitor of galectins" was invented by Fredrik Zetterberg (Askim, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a D-galactopyranose compound of formula (1) wherein the pyranose ring is Alpha-D-galactopyranose, and these compounds are high affinity galectin-1 and/or galectin 3 inhibitors for use in treatment of inflammation; fibrosis; scarring; keloid formation; aberrant scar formation; surgical adhesions; septic shock; cancer; metastasising cancers; autoimmune diseases, metabolic disorders; heart disease; heart fai...